Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC.
This research is being done because further research on selumetinib in combination with standard chemotherapy treatment is needed.
Three arms of the study include treatment with
a) paclitaxel and carboplain plus selumetinib
b) pemetrexed and cisplain plus selumetinib
c) pemetrexed plus selumetinib